Skip to main content

Paul Emery

Professor Paul Emery trained in Cambridge, London, and Birmingham in the UK. He is the Arthritis Research UK Professor of Rheumatology and Director of the NIHR Leeds Biomedical Research Centre. His previous roles include EULAR President 2009–2011, Chair of the Executive of FOREUM 2013–2019, and NIHR Senior Investigator since 2008.

Professor Emery is a recipient of the Roche Biennial Award for Clinical Rheumatology; the Rheumatology Hospital Doctor of the Year award 1999; the EULAR Prize 2002; and the Carol Nachman Prize 2012. In 2018 he was awarded an Order of the British Empire (OBE) by the Queen of the UK.

Professor Emery’s research interests center around the immunopathogenesis and immunotherapy of rheumatoid arthritis, spondyloarthritis, psoriatic arthritis and connective tissue diseases, and the prevention of autoimmune diseases. He has published more than 1100 peer-reviewed articles in this area, with an h-index of over 100.


Latest contributions from Paul Emery

Pills isolated on white background

07-06-2019 | Rheumatoid arthritis | Case study | Article

Tofacitinib in a patient with refractory severe rheumatoid arthritis

Paul Emery and John Fitton present the case of a patient who has responded to treatment with the JAK inhibitor tofacitinib as her sixth-line targeted therapy for biologic-refractory rheumatoid arthritis.